Article
An artificial intelligence-based model for prediction of clonal hematopoiesis variants in cell-free DNA samples
20 May 2025
Abstract excerpt
Circulating tumor DNA is a critical biomarker in cancer diagnostics, but its accurate interpretation requires careful consideration of clonal hematopoiesis (CH), which can contribute to variants in cell-free DNA and potentially obscure true tumor-derived signals. Accurate detection of somatic variants of CH origin in plasma samples remains challenging in the absence of matched white blood cells sequencing. Here...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
